🇺🇸 FDA
Pipeline program

Tirzepatide

HS-25-00642

Phase 2 small_molecule active

Quick answer

Tirzepatide for Smoking Cessation is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Smoking Cessation
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials